Maintenance electroconvulsive therapy in affective and schizoaffective disorder

Area of Science:

• Psychiatry
• Neurology
• Clinical Medicine

Background:

• Maintenance pharmacotherapy is standard for recurrent mood disorders.
• Long-term effectiveness and safety of maintenance treatments require ongoing evaluation.
• Electroconvulsive therapy (ECT) is an established treatment for severe mood episodes.

Purpose of the Study:

• To compare the effectiveness and safety of maintenance electroconvulsive therapy (M-ECT) versus maintenance pharmacotherapy alone.
• To evaluate rehospitalization rates and duration in patients with depressive and schizoaffective disorders.
• To assess M-ECT as a long-term treatment strategy.

Main Methods:

• Prospective 1-year follow-up study comparing M-ECT (n=21) with pharmacotherapy controls.
• Inclusion of patients with depressive and schizoaffective disorders.
• Utilized survival analysis to determine time to rehospitalization.

Main Results:

• M-ECT group showed significantly better outcomes regarding time to rehospitalization across all patients.
• Depressive patients receiving M-ECT had markedly reduced rehospitalization rates and duration.
• Schizoaffective patients on M-ECT also demonstrated significantly improved survival time.

Conclusions:

• M-ECT, combined with supportive medication, is an efficient and safe alternative to pharmacotherapy alone for selected patients.
• M-ECT demonstrates superior efficacy in reducing rehospitalization for both depressive and schizoaffective disorders.
• Schizoaffective disorder patients generally experienced poorer outcomes than depressive patients in this study.